PT UBC Medical Indonesia Tbk
PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. PT UBC Medical Indonesia Tbk was founded in 2014 and is based in Jakarta Timur… Read more
Market Cap & Net Worth: PT UBC Medical Indonesia Tbk (LABS)
PT UBC Medical Indonesia Tbk (JK:LABS) has a market capitalization of $37.39 Million (Rp608.30 Billion) as of March 19, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #30229 globally and #538 in its home market, demonstrating a 5.48% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PT UBC Medical Indonesia Tbk's stock price Rp154.00 by its total outstanding shares 3950000000 (3.95 Billion).
PT UBC Medical Indonesia Tbk Market Cap History: 2024 to 2026
PT UBC Medical Indonesia Tbk's market capitalization history from 2024 to 2026. Data shows growth from $32.53 Million to $37.39 Million (7.19% CAGR).
PT UBC Medical Indonesia Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PT UBC Medical Indonesia Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
PT UBC Medical Indonesia Tbk's market cap is 0.00 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
PT UBC Medical Indonesia Tbk's market cap is 0.01 times its annual earnings
1.94x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $32.53 Million | $147.64 Billion | $2.95 Billion | 0.00x | 0.01x |
Competitor Companies of LABS by Market Capitalization
Companies near PT UBC Medical Indonesia Tbk in the global market cap rankings as of March 19, 2026.
Key companies related to PT UBC Medical Indonesia Tbk by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
PT UBC Medical Indonesia Tbk Historical Marketcap From 2024 to 2026
Between 2024 and today, PT UBC Medical Indonesia Tbk's market cap moved from $32.53 Million to $ 37.39 Million, with a yearly change of 7.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp37.39 Million | +12.41% |
| 2025 | Rp33.26 Million | +2.24% |
| 2024 | Rp32.53 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of PT UBC Medical Indonesia Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $37.39 Million USD |
| MoneyControl | $37.39 Million USD |
| MarketWatch | $37.39 Million USD |
| marketcap.company | $37.39 Million USD |
| Reuters | $37.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.